Clinical Features of Combined Central Retinal Artery and Vein Occlusion

Table 2

BCVA at presentation, 2 to 3 weeks after presentation, and at last follow-up.

BCVA	At presentation	Two to 3 weeks after presentation	Last follow-up
≥20/60	4 (12.1%)	7 (21.9%)	6 (23.1%)
20/200–20/60	3 (9.1%)	6 (18.8%)	1 (3.8%)
20/400–20/200	0	4 (12.5%)	4 (15.4%)
20/2000–20/400	11 (33.3%)	11 (33.3%)	9 (34.6%)
FC, LP, or NLP	15 (45.5%)	4 (12.5%)	6 (23.1%)
Total (eyes)	33	32	26